Dietary Omega Polyunsaturated Fatty Acid Intake and Patient-Reported Outcomes in Systemic Lupus Erythematosus: The Michigan Lupus Epidemiology and Surveillance Program

被引:27
|
作者
Charoenwoodhipong, Prae [1 ]
Harlow, Sioban D. [1 ]
Marder, Wendy [1 ]
Hassett, Afton L. [1 ]
McCune, W. Joseph [1 ]
Gordon, Caroline [2 ]
Helmick, Charles G. [3 ]
Barbour, Kamil E. [3 ]
Wang, Lu [1 ]
Mancuso, Peter [1 ]
Somers, Emily C. [1 ]
Zick, Suzanna M. [1 ]
机构
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Univ Birmingham, Birmingham, W Midlands, England
[3] Ctr Dis Control & Prevent, Atlanta, GA USA
关键词
DISEASE-ACTIVITY; SLEEP; SUPPLEMENTATION; FIBROMYALGIA; VALIDATION; PROTECTINS; RESOLVINS; CRITERIA; QUALITY; TRIAL;
D O I
10.1002/acr.23925
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To examine associations between dietary intake of omega-3 (n-3; generally antiinflammatory) and omega-6 (n-6; generally proinflammatory) fatty acids and patient-reported outcomes in systemic lupus erythematosus (SLE). Methods This study was based on the population-based Michigan Lupus Epidemiology and Surveillance cohort. Estimates of n-3 and n-6 intake were derived from Diet History Questionnaire II items (past year with portion size version). Patient-reported outcomes included self-reported lupus activity (Systemic Lupus Activity Questionnaire [SLAQ]). Multivariable regression, adjusted for age, sex, race, and body mass index, was used to assess associations between absolute intake of n-3 and n-6, as well as the n-6:n-3 ratio, and patient-reported outcomes. Results Among 456 SLE cases, 425 (93.2%) were female, 207 (45.4%) were African American, and the mean +/- SD age was 52.9 +/- 12.3 years. Controlling for potential confounders, the average SLAQ score was significantly higher by 0.3 points (95% confidence interval [95% CI] 0.1, 0.6;P= 0.013) with each unit increase of the n-6:n-3 ratio. Both lupus activity and Patient-Reported Outcomes Measurement Information System (PROMIS) sleep disturbance scores were lower with each 1-gram/1,000 kcal increase of n-3 fatty acids (SLAQ regression coefficient beta = -0.8 [95% CI -1.6, 0.0];P= 0.055; PROMIS sleep beta = -1.1 [95% CI -2.0, -0.2];P= 0.017). Higher n-3 intakes were nonsignificantly associated with lower levels of depressive symptoms and comorbid fibromyalgia, and with higher quality of life, whereas results for the n6:n3 ratio trended in the opposite direction. Conclusion This population-based study suggests that higher dietary intake of n-3 fatty acids and lower n-6:n-3 ratios are favorably associated with patient-reported outcomes in SLE, particularly self-reported lupus activity and sleep quality.
引用
收藏
页码:874 / 881
页数:8
相关论文
共 50 条
  • [41] REMISSION AND LOW LUPUS DISEASE ACTIVITY (LLDAS) ARE ASSOCIATED WITH BETTER PATIENT-REPORTED OUTCOMES (PROS) IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS
    Ugarte-Gil, Manuel F.
    Gamboa-Cardenas, Rocio
    Reategui-Sokolova, Cristina
    Pimentel-Quiroz, Victor
    Medina, Mariela
    Elera-Fitzcarrald, Claudia
    Cucho-Venegas, Jorge M.
    Rodriguez-Bellido, Zoila
    Pastor-Asurza, Cesar
    Alarcon, Graciela S.
    Perich-Campos, Risto
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2021, 27 : S17 - S17
  • [42] Patient-Reported Outcomes in Systemic Lupus Erythematosus. Can Lupus Patients Take the Driver's Seat in Their Disease Monitoring?
    Parodis, Ioannis
    Studenic, Paul
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (02)
  • [43] Impact of pulmonary disease on patient-reported outcomes and patient-performed functional testing in systemic lupus erythematosus
    Fidler, L.
    Keen, K. J.
    Touma, Z.
    Mittoo, S.
    LUPUS, 2016, 25 (09) : 1004 - 1011
  • [44] Serum adipokine levels and associations with patient-reported fatigue in systemic lupus erythematosus
    Mahieu, Mary A.
    Ahn, Grace E.
    Chmiel, Joan S.
    Dunlop, Dorothy D.
    Helenowski, Irene B.
    Semanik, Pamela
    Song, Jing
    Yount, Susan
    Chang, Rowland W.
    Ramsey-Goldman, Rosalind
    RHEUMATOLOGY INTERNATIONAL, 2018, 38 (06) : 1053 - 1061
  • [45] Serum adipokine levels and associations with patient-reported fatigue in systemic lupus erythematosus
    Mary A. Mahieu
    Grace E. Ahn
    Joan S. Chmiel
    Dorothy D. Dunlop
    Irene B. Helenowski
    Pamela Semanik
    Jing Song
    Susan Yount
    Rowland W. Chang
    Rosalind Ramsey-Goldman
    Rheumatology International, 2018, 38 : 1053 - 1061
  • [46] Categorization of patients with systemic lupus erythematosus using disease activity, patient-reported outcomes, and transcriptomic signatures
    Arcani, Robin
    Jouve, Elisabeth
    Chiche, Laurent
    Jourde-Chiche, Noemie
    CLINICAL RHEUMATOLOGY, 2023, 42 (06) : 1555 - 1563
  • [47] Fatigue, health-related quality of life and other patient-reported outcomes in systemic lupus erythematosus
    Schmeding, A.
    Schneider, M.
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2013, 27 (03): : 363 - 375
  • [48] Literature review and recommendation of suitable tools for patient-reported outcomes (PRO) in systemic lupus erythematosus (SLE)
    Kielhorn, A.
    Dard, S.
    Staniek, V.
    Arnould, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 467 - 467
  • [49] Categorization of patients with systemic lupus erythematosus using disease activity, patient-reported outcomes, and transcriptomic signatures
    Robin Arcani
    Elisabeth Jouve
    Laurent Chiche
    Noémie Jourde-Chiche
    Clinical Rheumatology, 2023, 42 : 1555 - 1563
  • [50] CATEGORIZATION OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS USING DISEASE ACTIVITY, PATIENT-REPORTED OUTCOMES AND TRANSCRIPTOMIC SIGNATURES
    Arcani, R.
    Jouve, E.
    Chiche, L.
    Jourde-Chiche, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1062 - 1063